Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2022 12:30 ET | Source: BioNTech SE

Positive Phase-1-Daten von mRNA-basierter individualisierter Neoantigen-spezifischer Immuntherapie bei Patienten mit Bauchspeicheldrüsenkrebs auf ASCO vorgestellt

Vorläufige Analyse von Daten aus einer laufenden, nichtkommerziellen klinischen Phase-1-Studie (investigator-initiated), die von Forschenden am Memorial Sloan Kettering Cancer Center in New York...
June 05, 2022 12:30 ET | Source: BioNTech SE

Positive Phase 1 Data from mRNA-based Individualized Neoantigen Specific Immunotherapy in Patients with Resected Pancreatic Cancer presented at ASCO

Preliminary analysis of data from an ongoing investigator-initiated, single-center Phase 1 study supported by BioNTech and Genentech and conducted at Memorial Sloan Kettering Cancer Center, New York,...